| 主权项 |
1. A method for delivering an immunomodulator to a patient, comprising the steps of:
providing a patient consultation; ordering a test to determine an allergen to which patient has sensitivities; analyzing results of the test; designing a therapeutic program based on the results of the test; writing a script for the program; sending script to a compound pharmacist; providing a container of concentrated immunomodulator extract; diluting the immunomodulator extract by the steps of:
providing a plurality of sterile containers, each associated with a different dilution level;extracting a defined amount of concentrated immunomodulators extract from the container of immunomodulators extract and disposing it within a first one of the sterile containers containing a dilutant to provide a first dilution level;extracting a defined amount of the diluted immunomodulators at the first solution from the first of the sterile containers and disposing it within the second of the sterile containers to provide a second dilution level;progressively extracting a defined amount of diluted immunomodulators from a previous one of the sterile containers to the next thereof containing a dilutant to provide progressively more diluted levels until the last of the sterile containers containing a final dilution level such that all diluted concentrations are diluted; obtaining at a central control center National Drug Codes (NDC's) for a plurality of allergens at a defined concentration level, each NDC uniquely identifying that particular allergen as to its manufacture, the particular allergen, the packaging and the defined concentration level, and further obtaining information as to a description of the particular allergen, concentration level and manufacturer; determining by the central control center an Average Wholesale Price (AWP) for each of the allergens associated with each of the NDC's; storing in a central control database the obtained NDC's in association with an associated AWP and associated information for the allergen, which associated information includes translation information to allow practitioners to determine from a desired diluted level and number of doses of a desired NDC-carrying antigen and a known dilution procedure how to translate back to the amount of base concentration of the NDC-carrying antigen used to create the desired diluted level and number of doses; accessing a third-party database accessible by a pharmacist and determining if any of the NDC's in the central control database are contained within the third-party database and, if not:
transferring the associated NDC's not in the third-party database and that exist in the central control database for each of allergens to the third-party database in association with the AWP and associated information for each of the allergens for each of the NDC's, anduniquely associating each of the NDC's in the third-party database to the central control center for adjudication information; andcreating an adjudicating database at the central control center having defined benefits associated with reimbursable entities for each of the NDC's stored in the third-party database and in the central control database in association with the translation information for each of the NDC-carrying antigens, wherein a pharmacist can access this information by accessing a particular NDC in the third-party database to obtain information regarding reimbursable benefits from the central control center and enter the diluted level and number of doses and a claim with the central control center for adjudication of the amount of base concentrate antigen used and wherein the central control center is able to process any claim made by the pharmacist and reimburse the pharmacist accordingly for the base concentrate antigen used to provide the desired diluted level and number of doses of the desired NDC-carrying antigen. |
